Celldex Therapeutics | CLDX - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
AbbVie USD 10.27B 1000K 2026-06
Agenus USD -199.08M 22.15M 2026-06
Amgen USD 11.69B 6.9B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celldex Therapeutics USD 714.56M 258.34M 2026-06
Glaxosmithkline GBP 5.34B 3.83B 2026-03
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Northwest Biotherapeutics USD 11.39M 120.04M 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 18.9B 2.12B 2026-06